BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 30196327)

  • 1. 2017 revisions of McDonald criteria shorten the time to diagnosis of multiple sclerosis in clinically isolated syndromes.
    Gaetani L; Prosperini L; Mancini A; Eusebi P; Cerri MC; Pozzilli C; Calabresi P; Sarchielli P; Di Filippo M
    J Neurol; 2018 Nov; 265(11):2684-2687. PubMed ID: 30196327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of a multiple sclerosis diagnosis in patients with clinically isolated syndrome using the 2016 MAGNIMS and 2010 McDonald criteria: a retrospective study.
    Filippi M; Preziosa P; Meani A; Ciccarelli O; Mesaros S; Rovira A; Frederiksen J; Enzinger C; Barkhof F; Gasperini C; Brownlee W; Drulovic J; Montalban X; Cramer SP; Pichler A; Hagens M; Ruggieri S; Martinelli V; Miszkiel K; Tintorè M; Comi G; Dekker I; Uitdehaag B; Dujmovic-Basuroski I; Rocca MA
    Lancet Neurol; 2018 Feb; 17(2):133-142. PubMed ID: 29275979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application and a proposed modification of the 2010 McDonald criteria for the diagnosis of multiple sclerosis in a Canadian cohort of patients with clinically isolated syndromes.
    Kang H; Metz LM; Traboulsee AL; Eliasziw M; Zhao GJ; Cheng Y; Zhao Y; Li DK;
    Mult Scler; 2014 Apr; 20(4):458-63. PubMed ID: 23970502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnosis of multiple sclerosis: A review of the 2017 revisions of the McDonald criteria].
    Csépány T
    Ideggyogy Sz; 2018 Sep; 71(9-10):321-329. PubMed ID: 30335264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishing the diagnosis of multiple sclerosis in Croatian patients with clinically isolated syndrome: 2010 versus 2017 McDonald criteria.
    Habek M; Pavičić T; Ruška B; Pavlović I; Gabelić T; Barun B; Adamec I; Crnošija L; Krbot Skorić M
    Mult Scler Relat Disord; 2018 Oct; 25():99-103. PubMed ID: 30059896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of the 2017 McDonald diagnostic criteria for multiple sclerosis in Korean patients with clinically isolated syndrome.
    Hyun JW; Kim W; Huh SY; Park MS; Ahn SW; Cho JY; Kim BJ; Lee SH; Kim SH; Kim HJ
    Mult Scler; 2019 Oct; 25(11):1488-1495. PubMed ID: 30043667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conversion of clinically isolated syndrome to multiple sclerosis: a prospective study.
    Kolčava J; Kočica J; Hulová M; Dušek L; Horáková M; Keřkovský M; Stulík J; Dostál M; Kuhn M; Vlčková E; Bednařík J; Benešová Y
    Mult Scler Relat Disord; 2020 Sep; 44():102262. PubMed ID: 32570179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved performance of the 2017 McDonald criteria for diagnosis of multiple sclerosis in children in a real-life cohort.
    Hacohen Y; Brownlee W; Mankad K; Chong WK'; Thompson A; Lim M; Wassmer E; Hemingway C; Barkhof F; Ciccarelli O
    Mult Scler; 2020 Oct; 26(11):1372-1380. PubMed ID: 31317829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of the 2017 and 2010 Revised McDonald Criteria in Predicting MS Diagnosis After a Clinically Isolated Syndrome: A MAGNIMS Study.
    Filippi M; Preziosa P; Meani A; Dalla Costa G; Mesaros S; Drulovic J; Ivanovic J; Rovira A; Tintorè M; Montalban X; Ciccarelli O; Brownlee W; Miszkiel K; Enzinger C; Khalil M; Barkhof F; Strijbis EMM; Frederiksen JL; Cramer SP; Fainardi E; Amato MP; Gasperini C; Ruggieri S; Martinelli V; Comi G; Rocca MA;
    Neurology; 2022 Jan; 98(1):e1-e14. PubMed ID: 34716250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Periventricular lesions and MS diagnostic criteria in young adults with typical clinically isolated syndromes.
    Brownlee WJ; Miszkiel KA; Altmann DR; Ciccarelli O; Miller DH
    Mult Scler; 2017 Jun; 23(7):1031-1034. PubMed ID: 27600111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria.
    Thompson AJ; Banwell BL; Barkhof F; Carroll WM; Coetzee T; Comi G; Correale J; Fazekas F; Filippi M; Freedman MS; Fujihara K; Galetta SL; Hartung HP; Kappos L; Lublin FD; Marrie RA; Miller AE; Miller DH; Montalban X; Mowry EM; Sorensen PS; Tintoré M; Traboulsee AL; Trojano M; Uitdehaag BMJ; Vukusic S; Waubant E; Weinshenker BG; Reingold SC; Cohen JA
    Lancet Neurol; 2018 Feb; 17(2):162-173. PubMed ID: 29275977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early predictors of multiple sclerosis after a typical clinically isolated syndrome.
    Ruet A; Arrambide G; Brochet B; Auger C; Simon E; Rovira A; Montalban X; Tintoré M
    Mult Scler; 2014 Nov; 20(13):1721-6. PubMed ID: 24842960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High risk of early conversion to multiple sclerosis in clinically isolated syndromes with dissemination in space at baseline.
    Gaetani L; Fanelli F; Riccucci I; Eusebi P; Sarchielli P; Pozzilli C; Calabresi P; Prosperini L; Di Filippo M
    J Neurol Sci; 2017 Aug; 379():236-240. PubMed ID: 28716249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of conversion from clinically isolated syndrome to clinically definite multiple sclerosis according to baseline MRI findings: comparison of revised McDonald criteria and Swanton modified criteria.
    Lo CP; Kao HW; Chen SY; Hsueh CJ; Lin WC; Hsu WL; Wu DK; Liu GC
    J Neurol Neurosurg Psychiatry; 2009 Oct; 80(10):1107-9. PubMed ID: 19546108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on clinically isolated syndrome.
    Thouvenot É
    Presse Med; 2015 Apr; 44(4 Pt 2):e121-36. PubMed ID: 25813099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the 2010 McDonald multiple sclerosis criteria in children with a clinically isolated syndrome.
    Kornek B; Schmitl B; Vass K; Zehetmayer S; Pritsch M; Penzien J; Karenfort M; Blaschek A; Seidl R; Prayer D; Rostasy K
    Mult Scler; 2012 Dec; 18(12):1768-74. PubMed ID: 22526931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Should the symptomatic region be included in dissemination in space in MRI criteria for MS?
    Brownlee WJ; Swanton JK; Miszkiel KA; Miller DH; Ciccarelli O
    Neurology; 2016 Aug; 87(7):680-3. PubMed ID: 27421541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic value of the 2017 McDonald criteria in patients with a first demyelinating event suggestive of relapsing-remitting multiple sclerosis.
    Lee DH; Peschke M; Utz KS; Linker RA
    Eur J Neurol; 2019 Mar; 26(3):540-545. PubMed ID: 30362206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of the symptomatic lesion in establishing MS diagnosis and prognosis.
    Tintore M; Otero-Romero S; Río J; Arrambide G; Pujal B; Tur C; Galán I; Comabella M; Nos C; Arévalo MJ; Vidal-Jordana A; Castilló J; Rodríguez-Acevedo B; Midaglia L; Mitjana R; Auger C; Sastre-Garriga J; Rovira À; Montalban X
    Neurology; 2016 Sep; 87(13):1368-74. PubMed ID: 27566747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of the 2010 revised criteria for the diagnosis of multiple sclerosis to patients with clinically isolated syndromes.
    Runia TF; Jafari N; Hintzen RQ
    Eur J Neurol; 2013 Dec; 20(12):1510-6. PubMed ID: 23906114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.